Product: Capsulated KLOW Capsule Count: 60 capsules GHK-Cu: 2MG per capsule KPV: 500MCG per capsule TB-500: 500MCG per capsule BPC-157 Salt Arginate: 500MCG per capsule Total Active Content Per Capsule: 3.5MG Total GHK-Cu Content: 120MG Total KPV Content: 30MG Total TB-500 Content: 30MG Total BPC-157 Salt Arginate Content: 30MG Total Bottle Active Content: 210MG Format: GMP capsule research blend Research Category: Copper peptide / peptide-fragment / tissue-response pathway research Research Focus: Copper peptide signaling, extracellular matrix biology, dermal pathway models, peptide-fragment research, inflammation-response pathway studies, tissue-remodeling models, and cellular repair-associated signaling
CAT, catalase activities
In a retrospective review by Kellner et al, patients with RA who received GLP-1RA treatment achieved significantly greater reductions in body weight, total and low-density lipoprotein cholesterol, triglycerides, erythrocyte sedimentation rate, glycosylated hemoglobin, and C-reactive protein when compared against an untreated group with RA
It contains a significant source of organic sulfur (34%), which is found in plants, animals and is the third most abundant element in the human body after calcium and phosphorus
Acknowledgements This work is supported in part by NIH grants AA022057 (VV), AA021724 (VV)
How PlexusDx Supports a More Personalized Approach The PlexusDx Precision Peptide Genetic Test reports predispositions in GLP-1-related signaling pathways variants such as GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 that describe baseline appetite and weight-regulation biology
